QA: Rezolute Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2023_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 152,104,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 16,000
3 remainder_Assets 300,000
4 LiabilitiesCurrent 2,462,000
5 LiabilitiesNoncurrent 80,000
6 remainder_Liabilities 407,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,590,992
9 ResearchAndDevelopmentExpense 52,627,954
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,007,282
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 152,420,000
1 Liabilities 2,949,000
2 Expenses 62,218,946
3 Revenues 0
4 StockholdersEquity 149,471,000
5 NetIncome -61,211,664
6 ComprehensiveNetIncome -61,211,664
7 BaseVar 109,297,614
8 EconomicCapitalRatiobeforeLimitedLiability 3.41
9 EconomicCapitalRatio 3.96

Edgar->Model Mapping

Feature Distribution

Change over Time